These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22621269)

  • 1. Coagulopathy as a therapeutic target for TRALI: rationale and possible sites of action.
    Tuinman PR; Schultz MJ; Juffermans NP
    Curr Pharm Des; 2012; 18(22):3267-72. PubMed ID: 22621269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future preventive and therapeutic targets for transfusion-related acute lung injury.
    Curtis BR
    Curr Pharm Des; 2012; 18(22):3285-92. PubMed ID: 22621267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary coagulation and fibrinolysis abnormalities that favor fibrin deposition in the lungs of mouse antibody-mediated transfusion-related acute lung injury.
    Yu Y; Jiang P; Sun P; Su N; Lin F
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-neutrophil interactions as a target for prevention and treatment of transfusion-related acute lung injury.
    Caudrillier A; Looney MR
    Curr Pharm Des; 2012; 18(22):3260-6. PubMed ID: 22621270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State of the art management of transfusion-related acute lung injury (TRALI).
    Goldberg AD; Kor DJ
    Curr Pharm Des; 2012; 18(22):3273-84. PubMed ID: 22621274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Transfusion-Related Acute Lung Injury and Possible Transfusion-Related Acute Lung Injury Reported to the French Hemovigilance Network From 2007 to 2013.
    Andreu G; Boudjedir K; Muller JY; Pouchol E; Ozier Y; Fevre G; Gautreau C; Quaranta JF; Drouet C; Rieux C; Mertes PM; Clavier B; Carlier M; Sandid I
    Transfus Med Rev; 2018 Jan; 32(1):16-27. PubMed ID: 28864336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion reactions: newer concepts on the pathophysiology, incidence, treatment, and prevention of transfusion-related acute lung injury.
    Sayah DM; Looney MR; Toy P
    Crit Care Clin; 2012 Jul; 28(3):363-72, v. PubMed ID: 22713611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of CD62P during storage of apheresis platelet concentrates and the role of CD62P in transfusion-related acute lung injury.
    Tong S; Wang H; Zhang T; Chen L; Liu B
    Mol Med Rep; 2015 Nov; 12(5):7777-81. PubMed ID: 26397744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLATELET SUPPRESSION BY TIROFIBAN AMELIORATES PULMONARY COAGULATION AND FIBRINOLYSIS ABNORMALITIES IN THE LUNGS OF MOUSE ANTIBODY-MEDIATED TRANSFUSION-RELATED ACUTE LUNG INJURY.
    Yuan X; Jiang P; Qiao C; Su N; Sun P; Lin F; Li C
    Shock; 2023 Apr; 59(4):603-611. PubMed ID: 36640155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model.
    Vlaar AP; Hofstra JJ; Kulik W; van Lenthe H; Nieuwland R; Schultz MJ; Levi MM; Roelofs JJ; Tool AT; de Korte D; Juffermans NP
    Blood; 2010 Aug; 116(8):1360-8. PubMed ID: 20479286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion therapy and acute lung injury.
    Sokolovic M; Pastores SM
    Expert Rev Respir Med; 2010 Jun; 4(3):387-93. PubMed ID: 20524921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-related acute lung injury: an overview.
    Bayat B; Sachs UJ
    Curr Pharm Des; 2012; 18(22):3236-40. PubMed ID: 22621272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion-related acute lung injury: transfusion, platelets and biological response modifiers.
    Tariket S; Sut C; Hamzeh-Cognasse H; Laradi S; Pozzetto B; Garraud O; Cognasse F
    Expert Rev Hematol; 2016 May; 9(5):497-508. PubMed ID: 26855042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of transfusion-related acute lung injury.
    Looney MR; Gilliss BM; Matthay MA
    Curr Opin Hematol; 2010 Sep; 17(5):418-23. PubMed ID: 20601870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental models of transfusion-related acute lung injury.
    Gilliss BM; Looney MR
    Transfus Med Rev; 2011 Jan; 25(1):1-11. PubMed ID: 21134622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion-related acute lung injury: emerging importance of host factors and implications for management.
    Juffermans NP
    Expert Rev Hematol; 2010 Aug; 3(4):459-67. PubMed ID: 21083036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel in vivo ovine model of transfusion-related acute lung injury (TRALI).
    Tung JP; Fung YL; Nataatmadja M; Colebourne KI; Esmaeel HM; Wilson K; Barnett AG; Wood P; Silliman CC; Fraser JF
    Vox Sang; 2011 Feb; 100(2):219-30. PubMed ID: 20667072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-related acute lung injury: advances in understanding the role of proinflammatory mediators in its genesis.
    West FB; Silliman CC
    Expert Rev Hematol; 2013 Jun; 6(3):265-76. PubMed ID: 23782081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transfusion-related acute lung injury (TRALI)].
    Schweisfurth H; Sopivnik I; Moog R
    Pneumologie; 2014 Sep; 68(9):599-603. PubMed ID: 25046684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of non-antibody mediated transfusion-related acute lung injury from bench to bedside.
    Peters AL; van Hezel ME; Juffermans NP; Vlaar AP
    Blood Rev; 2015 Jan; 29(1):51-61. PubMed ID: 25277811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.